Influenza-induced innate immunity: Regulators of viral replication, respiratory tract pathology & adaptive immunity

Future Virology

Volumn 6, Issue 8, 2011, Pages 951-962

  Oslund, Karen L ^a   Baumgarth, Nicole ^a,b  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

antiviral immunity; cytokine; cytokine storm; influenza A; innate immunity; lung epithelium; respiratory tract; type I IFN; virulence

Indexed keywords

ALPHA INTERFERON; BETA INTERFERON; CD11B ANTIGEN; CD47 ANTIGEN; GAMMA INTERFERON; GAMMA INTERFERON INDUCIBLE PROTEIN 10; GLYCOPROTEIN P 15095; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; IMMUNOGLOBULIN G; IMMUNOGLOBULIN M; INTERCELLULAR ADHESION MOLECULE 1; INTERLEUKIN 1; INTERLEUKIN 18; INTERLEUKIN 1BETA; INTERLEUKIN 28; INTERLEUKIN 28B; INTERLEUKIN 29; INTERLEUKIN 6; INTERLEUKIN 8; LYMPHOCYTE FUNCTION ASSOCIATED ANTIGEN 1; MONOCYTE CHEMOTACTIC PROTEIN 1; RANTES; STAT1 PROTEIN; STAT2 PROTEIN; TOLL LIKE RECEPTOR 3; TOLL LIKE RECEPTOR 7; TUMOR NECROSIS FACTOR ALPHA; UNINDEXED DRUG; VASCULAR CELL ADHESION MOLECULE 1; VERY LATE ACTIVATION ANTIGEN 4;

ADAPTIVE IMMUNITY; AVIAN INFLUENZA VIRUS; B LYMPHOCYTE; CD8+ T LYMPHOCYTE; CYTOKINE PRODUCTION; DENDRITIC CELL; EPITHELIUM CELL; HUMAN; IMMUNOREGULATION; INFLUENZA; INFLUENZA VIRUS; INFLUENZA VIRUS A H5N1; INNATE IMMUNITY; LEUKOCYTE; LUNG ALVEOLUS EPITHELIUM; MACROPHAGE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; RESPIRATORY TRACT DISEASE; REVIEW; VIRUS REPLICATION; VIRUS VIRULENCE;

AVES; ORTHOMYXOVIRIDAE;

EID: 80051984810     PISSN: 17460794     EISSN: 17460808     Source Type: Journal    
DOI: 10.2217/fvl.11.63     Document Type: Review

References (86)

1. Korteweg C, Gu J. Pathology, molecular biology, and pathogenesis of avian influenza A (H5N1) infection in humans. Am. J. Pathol. 172, 1155-1170 (2008).
2. Gill JR, Sheng ZM, Ely SF et al. Pulmonary pathologic findings of fatal 2009 pandemic influenza A/H1N1 viral infections. Arch. Pathol. Lab. Med. 134(2), 235-243 (2010).
3. Guarner J, Falcon-Escobedo R. Comparison of the pathology caused by H1N1, H5N1 and H3N2 influenza viruses. Arch. Med. Res. 40, 7 (2009).
4. Ramos I, Bernal-Rubio D, Durham N et al. Effects of receptor binding specificity of avian influenza virus on the human innate immune response. J. Virol. DOI: 10.1128/JVI.02356- 10 (2011).
5. Kanneganti TD. Central roles of NLRs and inflammasomes in viral infection. Nat. Rev. Immunol. 10, 688-698 (2010).
6. Le Goffic R, Balloy V, Lagranderie M et al. Detrimental contribution of the Toll-like receptor (TLR)3 to influenza A virus-induced acute pneumonia. PLoS Pathog. 2, E53 (2006).
7. Le Goffic R, Pothlichet J, Vitour D et al. Cutting edge: influenza A virus activates TLR3-dependent inflammatory and RIG-I-dependent antiviral responses in human lung epithelial cells. J. Immunol. 178, 3368-3372 (2007).
8. Pichlmair A, Schulz O, Tan CP et al. RIG-I-mediated antiviral responses to single-stranded RNA bearing 5'-phosphates. Science 314, 997-1001 (2006).
9. Siren J, Imaizumi T, Sarkar D et al. Retinoic acid inducible gene-I and mda-5 are involved in influenza A virus-induced expression of antiviral cytokines. Microbes Infect. 8, 2013-2020 (2006).
10. Xing Z, Harper R, Anunciacion J et al. Host immune and apoptotic responses to avian influenza virus H9N2 in human tracheobronchial epithelial cells. Am. J. Respir. Cell Mol. Biol. 44, 24-33 (2011).
11. Heer AK, Shamshiev A, Donda A et al. TLR signaling fine-tunes anti-influenza B cell responses without regulating effector T cell responses. J. Immunol. 178, 2182-2191 (2007).
12. Jewell NA, Cline T, Mertz SE et al. l interferon is the predominant interferon induced by influenza A virus infection in vivo. J. Virol. 84, 11515-11522 (2010).
13. Coro ES, Chang WL, Baumgarth N. Type I IFN receptor signals directly stimulate local B cells early following influenza virus infection. J. Immunol. 176, 4343-4351 (2006).
14. Gu J, Xie Z, Gao Z et al. H5N1 infection of the respiratory tract and beyond: a molecular pathology study. Lancet 370, 1137-1145 (2007).
15. Chan MC, Cheung CY, Chui WH et al. Proinflammatory cytokine responses induced by influenza A (H5N1) viruses in primary human alveolar and bronchial epithelial cells. Respir. Res. 6, 135 (2005).
16. Haller O, Staeheli P, Kochs G. Protective role of interferon-induced Mx GTPases against influenza viruses. Rev. Sci. Tech. 28(1), 219-231 (2009).
17. Samuel CE. Antiviral actions of interferons. Clin. Microbiol. Rev. 14, 778-809 (2001).
18. Trinchieri G. Type I interferon: friend or foe? J. Exp. Med. 207(10), 2053-2063 (2010).
19. Durbin JE, Hackenmiller R, Simon MC, Levy DE. Targeted disruption of the mouse Stat1 gene results in compromised innate immunity to viral disease. Cell 84, 443-450 (1996).
20. Sanders CJ, Doherty PC, Thomas PG. Respiratory epithelial cells in innate immunity to influenza virus infection. Cell Tissue Res. 343, 8 (2011).
21. Chan MC, Chan RW, Yu WC et al. Tropism and innate host responses of the 2009 pandemic H1N1 influenza virus in ex vivo and in vitro cultures of human conjunctiva and respiratory tract. Am. J. Pathol. 176, 1828-1840 (2010).
22. Lam WY, Yeung AC, Chu IM, Chan PK. Profiles of cytokine and chemokine gene expression in human pulmonary epithelial cells induced by human and avian influenza viruses. Virol. J. 7, 344 (2010).
23. Herold S, von Wulffen W, Steinmueller M et al. Alveolar epithelial cells direct monocyte transepithelial migration upon influenza virus infection: impact of chemokines and adhesion molecules. J. Immunol. 177, 1817-1824 (2006).
24. Perrone LA, Plowden JK, Garcia-Sastre A, Katz JM, Tumpey TM. H5N1 and 1918 pandemic influenza virus infection results in early and excessive infiltration of macrophages and neutrophils in the lungs of mice. PLoS Pathog. 4, E1000115 (2008).
25. Wijburg OL, DiNatale S, Vadolas J, van Rooijen N, Strugnell RA. Alveolar macrophages regulate the induction of primary cytotoxic T-lymphocyte responses during influenza virus infection. J. Virol. 71, 9450-9457 (1997).
26. Guo RF, Ward PA. Mediators and regulation of neutrophil accumulation in inflammatory responses in lung: insights from the IgG immune complex model. Free Radic. Biol. Med. 33, 303-310 (2002).
27. Schmitz N, Kurrer M, Bachmann MF, Kopf M. Interleukin-1 is responsible for acute lung immunopathology but increases survival of respiratory influenza virus infection. J. Virol. 79, 6441-6448 (2005).
28. Kidney JC, Proud D. Neutrophil transmigration across human airway epithelial monolayers: mechanisms and dependence on electrical resistance. Am. J. Respir. Cell Mol. Biol. 23, 389-395 (2000).
29. Rosseau S, Selhorst J, Wiechmann K et al. Monocyte migration through the alveolar epithelial barrier: adhesion molecule mechanisms and impact of chemokines. J. Immunol. 164, 427-435 (2000).
30. Kohlmeier JE, Cookenham T, Roberts AD, Miller SC, Woodland DL. Type I interferons regulate cytolytic activity of memory CD8(+) T cells in the lung airways during respiratory virus challenge. Immunity 33, 96-105 (2010).
31. Ichinohe T, Lee HK, Ogura Y, Flavell R, Iwasaki A. Inflammasome recognition of influenza virus is essential for adaptive immune responses. J. Exp. Med. 206, 79-87 (2009).
32. Thomas PG, Dash P, Aldridge JR et al. The intracellular sensor NLRP3 mediates key innate and healing responses to influenza A virus via the regulation of caspase-1. Immunity 30, 566-575 (2009).
33. Chang WL, Coro ES, Rau FC, Xiao Y, Erle DJ, Baumgarth N. Influenza virus infection causes global respiratory tract B cell response modulation via innate immune signals. J. Immunol. 178, 1457-1467 (2007).
34. Le Bon A, Thompson C, Kamphuis et al. Cutting edge: enhancement of antibody responses through direct stimulation of B and T cells by type I IFN. J. Immunol. 176, 2074-2078 (2006).
35. Jego G, Palucka AK, Blanck JP, Chalouni C, Pascual V, Banchereau J. Plasmacytoid dendritic cells induce plasma cell differentiation through type I interferon and interleukin 6. Immunity 19, 225-234 (2003).
36. Le Bon A, Schiavoni G, D'Agostino G, Gresser I, Belardelli F, Tough DF. Type I interferons potently enhance humoral immunity and can promote isotype switching by stimulating dendritic cells in vivo. Immunity 14, 461-470 (2001).
37. Avalos AM, Busconi L, Marshak-Rothstein A. Regulation of autoreactive B cell responses to endogenous TLR ligands. Autoimmunity 43, 76-83 (2010).
38. Osterlund P, Pirhonen J, Ikonen N et al. Pandemic H1N1 2009 influenza A virus induces weak cytokine responses in human macrophages and dendritic cells and is highly sensitive to the antiviral actions of interferons. J. Virol. 84, 1414-1422 (2010).
39. Wang X, Li M, Zheng H et al. Influenza A virus NS1 protein prevents activation of NF- kB and induction of a/binterferon. J. Virol. 74, 11566-11573 (2000).
40. Manicassamy B, Manicassamy S, Belicha- Villanueva A, Pisanelli G, Pulendran B, Garcia-Sastre A. Analysis of in vivo dynamics of influenza virus infection in mice using a GFP reporter virus. Proc. Natl Acad. Sci. USA 107, 11531-11536 (2010).
41. Geiler J, Michaelis M, Sithisarn P, Cinatl J Jr. Comparison of pro-inflammatory cytokine expression and cellular signal transduction in human macrophages infected with different influenza A viruses. Med. Microbiol. Immunol. 200, 53-60 (2011).
42. Lee SM, Gardy JL. Cheung CY et al. Systems-level comparison of host-responses elicited by avian H5N1 and seasonal H1N1 influenza viruses in primary human macrophages. PLoS One 4, E8072 (2009).
43. Monteerarat Y, Sakabe S, Ngamurulert S et al. Induction of TNF-ain human macrophages by avian and human influenza viruses. Arch. Virol. 155, 1273-1279 (2010).
44. Sakabe S, Iwatsuki-Horimoto K, Takano R et al. Cytokine production by primary human macrophages infected with highly pathogenic H5N1 or pandemic H1N1 2009 influenza viruses. J. Gen. Virol. 92, 1428-1434 (2011).
45. Woo PC, Tung ET, Chan KH, Lau CC, Lau SK, Yuen KY. Cytokine profiles induced by the novel swine-origin influenza A/H1N1 virus: implications for treatment strategies. J. Infect. Dis. 201, 346-353 (2010).
46. Wu W, Booth JL, Duggan ES et al. Innate immune response to H3N2 and H1N1 influenza virus infection in a human lung organ culture model. Virology 396, 178-188 (2010).
47. Lee SM, Cheung CY, Nicholls JM et al. Hyperinduction of cyclooxygenase-2- mediated proinflammatory cascade: a mechanism for the pathogenesis of avian influenza H5N1 infection. J. Infect. Dis. 198, 525-535 (2008).
48. Yarilina A, Park-Min KH. Antoniv T, Hu X, Ivashkiv LB. TNF activates an IRF1- dependent autocrine loop leading tosustained expression of chemokines and STAT1-dependent type I interferon-response genes. Nat. Immunol. 9, 378-387 (2008).
49. Perrone LA, Szretter KJ, Katz JM, Mizgerd JP, Tumpey TM. Mice lacking both TNF and IL-1 receptors exhibit reduced lung inflammation and delay in onset of death following infection with a highly virulent H5N1 virus. J. Infect. Dis. 202, 1161-1170 (2010).
50. Belisle SE, Tisoncik JR, Korth MJ et al. Genomic profiling of tumor necrosis factor a(TNF-a) receptor and interleukin-1 receptor knockout mice reveals a link between TNF-asignaling and increased severity of 1918 pandemic influenza virus infection. J. Virol. 84, 12576-12588 (2010).
51. Murphy EA, Davis JM, McClellan JL, Carmichael MD, Rooijen NV, Gangemi JD. Susceptibility to infection and inflammatory response following influenza virus (H1N1, A/PR/8/34) challenge: role of macrophages. J. Interferon Cytokine Res. 31(6), 501-508 (2011).
52. Tate MD, Pickett DL, van Rooijen N, Brooks AG, Reading PC. Critical role of airway macrophages in modulating disease severity during influenza virus infection of mice. J. Virol. 84, 7569-7580 (2010).
53. Mosser DM, Edwards JP. Exploring the full spectrum of macrophage activation. Nat. Rev. Immunol. 8, 958-969 (2008).
54. Diebold SS, Kaisho T, Hemmi H, Akira S, Reis e Sousa C. Innate antiviral responses by means of TLR7-mediated recognition of single-stranded RNA. Science 303, 1529-1531 (2004).
55. Hao X, Kim TS, Braciale TJ. Differential response of respiratory dendritic cell subsets to influenza virus infection. J. Virol. 82, 4908-4919 (2008).
56. Sandbulte MR, Boon AC, Webby RJ, Riberdy JM. Analysis of cytokine secretion from human plasmacytoid dendritic cells infected with H5N1 or low-pathogenicity influenza viruses. Virology 381, 22-28 (2008).
57. Thitithanyanont A, Engering A, Ekchariyawat P et al. High susceptibility of human dendritic cells to avian influenza H5N1 virus infection and protection by IFN-aand TLR ligands. J. Immunol. 179, 5220-5227 (2007).
58. Piqueras B, Connolly J, Freitas H, Palucka AK, Banchereau J. Upon viral exposure, myeloid and plasmacytoid dendritic cells produce 3 waves of distinct chemokines to recruit immune effectors. Blood 107, 2613-2618 (2006).
59. Subbarao K, Klimov A, Katz J et al. Characterization of an avian influenza A (H5N1) virus isolated from a child with a fatal respiratory illness. Science 279, 393-396 (1998).
60. Kash JC, Tumpey TM, Proll SC et al. Genomic analysis of increased host immune and cell death responses induced by 1918 influenza virus. Nature 443, 578-581 (2006).
61. Tumpey TM, Basler CF, Aguilar PV et al. Characterization of the reconstructed 1918 Spanish influenza pandemic virus. Science 310, 77-80 (2005).
62. Cheung CY, Poon LL, Lau AS et al. Induction of proinflammatory cytokines in human macrophages by influenza A (H5N1) viruses: a mechanism for the unusual severity of human disease? Lancet 360, 1831-1837 (2002).
63. Hui KP, Lee SM, Cheung CY et al. (2009).Induction of proinflammatory cytokines in primary human macrophages by influenza A virus (H5N1) is selectively regulated by IFN regulatory factor 3 and p38 MAPK. J. Immunol. 182, 1088-1098 (2009).
64. Mok KP, Wong CH, Cheung CY et al. Viral genetic determinants of H5N1 influenza viruses that contribute to cytokine dysregulation. J. Infect. Dis. 200, 1104-1112 (2009).
65. Baumgarth N, Kelso A. In vivo blockade of g interferon affects the influenza virus-induced humoral and the local cellular immune response in lung tissue. J. Virol. 70, 4411-4418 (1996).
66. Baskin CR, Bielefeldt-Ohmann H, Tumpey TM et al. Early and sustained innate immune response defines pathology and death in nonhuman primates infected by highly pathogenic influenza virus. Proc. Natl. Acad. Sci. USA 106, 3455-3460 (2009).
67. Cameron CM, Cameron MJ, Bermejo-Martin JF et al. Gene expression analysis of host innate immune responses during lethal H5N1 infection in ferrets. J. Virol. 82, 11308-11317 (2008).
68. Cilloniz C, Shinya K, Peng X et al. Lethal influenza virus infection in macaques is associated with early dysregulation of inflammatory related genes. PLoS Pathog. 5, E1000604 (2009).
69. Arankalle VA, Lole KS, Arya RP et al. Role of host immune response and viral load in the differential outcome of pandemic H1N1 (2009) influenza virus infection in Indian patients. PLoS One 5(10), E13099 (2010).
70. Fernandez-Sesma A, Marukian S, Ebersole BJ et al. Influenza virus evades innate and adaptive immunity via the NS1 protein. J. Virol. 80, 6295-6304 (2006).
71. Haye K, Burmakina S, Moran T, Garcia-Sastre A, Fernandez-Sesma A. The NS1 protein of a human influenza virus inhibits type I interferon production and the induction of antiviral responses in primary human dendritic and respiratory epithelial cells. J. Virol. 83, 6849-6862 (2009).
72. Guo Z, Chen LM, Zeng H et al. NS1 protein of influenza A virus inhibits the function of intracytoplasmic pathogen sensor, RIG-I. Am. J. Respir. Cell Mol. Biol. 36, 263-269 (2007).
73. Billharz R, Zeng H, Proll SC et al. The NS1 protein of the 1918 pandemic influenza virus blocks host interferon and lipid metabolism pathways. J. Virol. 83, 10557-10570 (2009).
74. Hale BG, Randall RE, Ortin J, Jackson D. The multifunctional NS1 protein of influenza A viruses. J. Gen. Virol. 89, 2359-2376 (2008).
75. Jia D, Rahbar R, Chan RW et al. Influenza virus non-structural protein 1 (NS1) disrupts interferon signaling. PLoS One 5, E13927 (2010).
76. Kochs G, Garcia-Sastre A, Martinez-Sobrido L. Multiple anti-interferon actions of the influenza A virus NS1 protein. J. Virol. 81, 7011-7021 (2007).
77. Kuo RL. Zhao C, Malur M, Krug RM. Influenza A virus strains that circulate in humans differ in the ability of their NS1 proteins to block the activation of IRF3 and interferon- btranscription. Virology 408, 146-158 (2010).
78. Ludwig S, Wang X, Ehrhardt C et al. The influenza A virus NS1 protein inhibits activation of Jun N-terminal kinase and AP-1 transcription factors. J. Virol. 76, 11166-11171 (2002).
79. Lipatov AS, Andreansky S, Webby RJ et al. Pathogenesis of Hong Kong H5N1 influenza virus NS gene reassortants in mice: the role of cytokines and B- and T-cell responses. J. Gen. Virol. 86, 1121-1130 (2005).
80. Itoh Y, Shinya K, Kiso M et al. In vitro and in vivo characterization of new swine-origin H1N1 influenza viruses. Nature 460, 1021-1025 (2009).
81. Kang YM, Song BM, Lee JS, Kim HS, Seo SH. Pandemic H1N1 influenza virus causes a stronger inflammatory response than seasonal H1N1 influenza virus in ferrets. Arch. Virol. 156(5), 759-767 (2011).
82. Rowe T, Leon AJ, Crevar CJ et al. Modeling host responses in ferrets during A/ California/07/2009 influenza infection. Virology 401, 257-265 (2010).
83. de Jong MD, Simmons CP, Thanh TT et al. Fatal outcome of human influenza A (H5N1) is associated with high viral load and hypercytokinemia. Nat. Med. 12, 1203-1207 (2006).
84. Uiprasertkul M, Puthavathana P, Sangsiriwut K et al. Influenza A H5N1 replication sites in humans. Emerg. Infect. Dis. 11, 1036-1041 (2005).
85. To KF, Chan PK, Chan KF et al. Pathology of fatal human infection associated with avian influenza A H5N1 virus. J. Med. Virol. 63, 242-246 (2001).
86. Peiris JS, Yu WC, Leung CW et al. Re-emergence of fatal human influenza A subtype H5N1 disease. Lancet 363, 617-619 (2004).